Overview

Signos offers a wearable device and an app designed to help users manage their metabolism and achieve health goals, particularly in the areas of weight loss and blood sugar control. The wearable device tracks real-time blood sugar levels, while the app provides personalized recommendations based on individual metabolic responses to food. Users can access features such as nutritionist support, predictive glucose insights for meals, tips on fasting and meal timing, exercise recommendations, and alerts for glucose spikes. Signos operates on a subscription model, allowing users to receive the device and app features for a fee. Unlike many competitors, Signos leverages AI technology that analyzes millions of data points to deliver tailored advice, making it easier for users to make informed dietary and lifestyle choices. The company's goal is to empower individuals to improve their health and well-being through personalized metabolic management.

Simplify's Take

What believers are saying

• Recent $20M funding round supports growth and expansion opportunities for Signos.
• Growing demand for personalized health solutions aligns with Signos' offerings.
• Integration with smart devices enhances user experience and retention.

What critics are saying

• Weight-loss drugs like Ozempic may reduce demand for Signos' wearable devices.
• Lack of FDA approval could limit credibility and user adoption.
• Increasing competition from similar health-tech startups may dilute market share.

What makes Signos unique

• Signos offers real-time blood sugar tracking with personalized metabolic recommendations.
• The app integrates with popular platforms like Fitbit and MyFitnessPal for comprehensive tracking.
• Signos uses AI technology to analyze millions of data points for personalized health advice.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$33M

Below

Industry Average

Funded Over

2 Rounds

$20,000,000

Series B

Oct 2023

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Below Average

Industry standards

Ind Avg. $35M

$4M

$20M

$30M

$45M

$65M

$100M

View all funding stages